Immunogenes Ltd. elaborated a patentable method to create transgenic animals producing policlonal and monoclonal antibodies to be used in therapies, diagnostics and research.
The patented technology gives the possibility of real-time in vivo identification of cancerous tissue during the surgery.
The product serves to treat everyday anxiety effectively and harmlessly without side effects. Anxiety is a problem affecting 20% of the population in the developed countries.
Established by the support of The National Office for Research and Technology.
ValDeal Innovations is a full member of the European Business and Innovation Centre Network.
ValDeal has been granted with the licence of European Business and Innovation Centre by the EBN.